Intrommune Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy for Food Allergy
08 mars 2019 10h01 HE
|
Intrommune Therapeutics
New York, March 08, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...
Harpoon Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results
07 mars 2019 16h05 HE
|
Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers,...
BriaCell Therapeutics Corp. Highlights Recent Clinical and Scientific Achievements in Exclusive Audio Interview with NetworkNewsWire
07 mars 2019 06h30 HE
|
NetworkNewsWire
NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- via NetworkWire - NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness...
Todos Medical Raises $1,350,500 In Funding and Finalizes Joint Venture Agreement with Amarantus Bioscience
28 févr. 2019 09h30 HE
|
Todos Medical Ltd.; Amarantus Bioscience Holdings, Inc.
JV to focus on the development of Alzheimer’s blood diagnostic LymPro Test 2.0 REHOVOT, Israel and NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage...
CCAB announces creation of new brain cancer therapeutic company, Empirica Therapeutics, as part of its strategy to advance new early-stage life sciences companies
20 févr. 2019 10h30 HE
|
Centre for the Commercialization of Antibodies and Biologics
TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- The Centre for the Commercialization of Antibodies and Biologics (CCAB) today announced a license agreement with Empirica Therapeutics Inc. aimed at...
Harpoon Therapeutics to Present at SVB Leerink Global Healthcare Conference
20 févr. 2019 07h30 HE
|
Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers,...
Intensity Therapeutics to Participate in Panel at 2019 BIO CEO & Investor Conference
05 févr. 2019 07h35 HE
|
Intensity Therapeutics Inc
WESTPORT, Conn., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary technology and products to kill tumors and increase...
Innovest Global Adds $600,000 to Call Center Contract
01 févr. 2019 09h00 HE
|
Innovest Global, Inc
CLEVELAND, Ohio, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST) (the "Company" or "Innovest"), a conglomerate with operations in commercial and industrial products and...